Pre-existing neutralizing antibody provides the first line of defence against pathogens in
general. For influenza virus, annual vaccinations are given to maintain protective levels of …

The 2009 pandemic H1N1 influenza pandemic demonstrated the global health threat of
reassortant influenza strains. Herein, we report a detailed analysis of plasmablast and …

We describe herein a protocol for the production of antigen-specific human monoclonal
antibodies (hmAbs). Antibody-secreting cells (ASCs) are isolated from whole blood collected 7 d …

Emerging evidence indicates a central role for the microbiome in immunity. However, causal
evidence in humans is sparse. Here, we administered broad-spectrum antibiotics to healthy …

We have previously shown that broadly neutralizing antibodies reactive to the conserved
stem region of the influenza virus hemagglutinin (HA) were generated in people infected with …

The p38 mitogen‐activated protein kinase is a stress‐activated enzyme responsible for
transducing inflammatory signals and initiating apoptosis. In the Alzheimer's disease (AD) brain, …

The human antibody repertoire is one of the most important defenses against infectious
disease, and the development of vaccines has enabled the conferral of targeted protection to …

Antibodies to the hemagglutinin (HA) and neuraminidase (NA) glycoproteins are the major
mediators of protection against influenza virus infection. Here, we report that current influenza …

During seasonal influenza epidemics, disease burden is shouldered predominantly by the
very young and the elderly. Elderly individuals are particularly affected, in part because …

Interaction of a B cell expressing self-specific B-cell antigen receptor (BCR) with an auto-antigen
results in either clonal deletion or functional inactivation 1 , 2 , 3 . Both of these …